Scientific Sessions 2024  /  Navigating the Wilderness: The Intersection of Immunology and Cardiovascular Disease  /  Bench to Bedside: Applying Immuno-Oncology to Improve Cardiovascular Health
Logo

American Heart Association

  111
  0

Final ID:

Bench to Bedside: Applying Immuno-Oncology to Improve Cardiovascular Health

  • Jimenez, Jesus  ( Washington University School of Med , Saint Louis , Missouri , United States )
  • Salem, Joe-elie  ( Sorbonne , Paris , France )
  • Moslehi, Javid  ( UCSF , San Francisco , California , United States )
  • Lavine, Kory  ( WASHINGTON UNIVERSITY SCHOOL OF MED , Saint Louis , Missouri , United States )
  • Jensen, Brian  ( UNC Chapel Hill , Chapel Hill , North Carolina , United States )
    • Author Disclosures:
    Jesus Jimenez: DO NOT have relevant financial relationships | Joe-elie Salem: DO have relevant financial relationships ; Consultant:BeiGene:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) | Javid Moslehi: DO NOT have relevant financial relationships | Kory Lavine: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen:Active (exists now) ; Advisor:Implicit Biosciences:Active (exists now) ; Advisor:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Bitterroot:Active (exists now) ; Research Funding (PI or named investigator):Implicit Biosciences:Active (exists now) ; Research Funding (PI or named investigator):Kiniksa:Past (completed) ; Research Funding (PI or named investigator):Novartis:Active (exists now) | Brian Jensen: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Navigating the Wilderness: The Intersection of Immunology and Cardiovascular Disease

Saturday, 11/16/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Targeting the Immune System in Anthracycline Cardiotoxicity

Alcaide Pilar

Immune Checkpoints as Therapeutic Targets in Heart Failure

Varga Zoltan, Meijers Wouter, Zaha Vlad

More abstracts from these authors:
Combined OX40-PD-1 immunotherapy potentiates cardiac inflammation and promotes myocardial vulnerability

Ma Pan, Lin Chieh-yu, Jimenez Jesus, Moslehi Javid, Lavine Kory, Villanueva Ana, Talukder Sejuti, He Ruijun, Wu Guanhua, Wang Xiaoran, Bell Lauren, Bredemeyer Andrea, Egawa Takeshi

CD40 is an immune checkpoint regulator that potentiates myocardial inflammation through activation and expansion of CCR2+ macrophages and CD8 T-cells

Jimenez Jesus, Amrute Junedh, Ma Pan, Wang Xiaoran, Dai Raymond, Lavine Kory

You have to be authorized to contact abstract author. Please, Login
Not Available